SR biotek Inc. (XKON:270210)
South Korea
· Delayed Price · Currency is KRW
30,400
-1,950 (-6.03%)
At close: Aug 14, 2025, 3:30 PM KST
SR biotek Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2016 | FY 2015 |
Aug '25 Aug 15, 2025 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
Debt / Equity Ratio | 3.15 | 3.15 | 2.95 |
Debt / EBITDA Ratio | 5.69 | 5.69 | 2.82 |
Debt / FCF Ratio | 76.38 | 76.38 | - |
Asset Turnover | 0.61 | 0.61 | - |
Inventory Turnover | 2.98 | 2.98 | - |
Quick Ratio | 0.45 | 0.45 | 0.72 |
Current Ratio | 0.78 | 0.78 | 1.26 |
Return on Equity (ROE) | -13.21% | -13.21% | - |
Return on Assets (ROA) | 1.20% | 1.20% | - |
Return on Capital (ROIC) | 1.37% | 1.37% | - |
Return on Capital Employed (ROCE) | 3.10% | 3.10% | 21.30% |
Buyback Yield / Dilution | - | -0.02% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.